2007 Impact Factor: 1.978
© Thomson ISI Journal Citation Reports 2008

The journal Biomarkers brings together all aspects of the rapidly growing field of biomarker research, encompassing their various uses and applications in one essential source.

The journal has enlarged its scope to include the expanding area of biomarkers of disease and now intends to include evidence-based pharmacodynamic markers. Biomarkers, now more than ever, provides a vital forum for the exchange of ideas and techniques in all areas of biomarker research. High quality papers in four main areas are accepted and manuscripts describing novel biomarkers and their subsequent validation are especially encouraged:

Biomarkers of disease: covering measurement of endogenous substances or parameters indicative of a disease process and the use of pharmacodynamic and genetic markers in evidence-based laboratory medicine and treatment (markers of efficacy);
Biomarkers of exposure: covering detection and measurement of internal exposure to drugs and other chemicals;
Biomarkers of response: including measures of endogenous substances or parameters indicative of pathological or biochemical changes both toxicodynamic and pharmacodynamic, resulting from exposure to drugs and other chemicals;
Biomarkers of susceptibility:: including genetic factors which alter susceptibility to drugs and other chemicals.

Manuscripts can describe biomarkers measured in humans or other animals in vivo or in vitro. Biomarkers will consider publishing negative data from studies of biomarkers of susceptibility in human populations.

The emphasis will be on demonstrating relationships between markers and effects rather than methodological papers unless they describe novel techniques.